Nykode Therapeutics AS (VACBF) Q4 2024 Earnings

26NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.044564
Actual EPS
-0.039606
Surprise EPS
0
Surprise Percent
+11.13%

Description

Nykode Therapeutics AS (VACBF) has reported earnings of -0.039606 per share for Q4 2024.

0 Comments

Share your thoughts